Shay Ben-Shachar

Shay Ben-Shachar

Auto-generated profile, based on publicly available information

Shay Ben-Shachar

Genetics Institute, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
SBShay Ben-Shachar
Shay Ben-Shachar
TDTom Dubov
Tom Dubov
HTHagit Toledano-Alhadef
Hagit Toledano-Alhadef
JMJacob Mashiah
Jacob Mashiah
ESEli Sprecher
Eli Sprecher
LMLudwine M. Messiaen
Ludwine M. Messiaen

10 October 2012 in European Journal of Human Genetics
Verified
Journal Article
Closed access
SBShay Ben-Shachar
Shay Ben-Shachar
SCShlomi Constantini
Shlomi Constantini
HHHen Hallevi
Hen Hallevi
ESEmma K Sach
Emma K Sach
MUMeena Upadhyaya
Meena Upadhyaya
SHSusan M Huson
Susan M Huson

1 December 2015 in Seminars in Pediatric Neurology
Verified
Journal Article
Closed access
BSBen Shofty
Ben Shofty
SCShlomi Constantini
Shlomi Constantini
SBShay Ben-Shachar
Shay Ben-Shachar

28 August 2015 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TDTom Dubov
Tom Dubov
HTHagit Toledano-Alhadef
Hagit Toledano-Alhadef
GCGil Chernin
Gil Chernin
SCShlomi Constantini
Shlomi Constantini
RCRoxana Cleper
Roxana Cleper
SBShay Ben-Shachar
Shay Ben-Shachar

16 June 2016 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
TDTom Dubov
Tom Dubov
HTHagit Toledano‐Alhadef
Hagit Toledano‐Alhadef
FBFelix Bokstein
Felix Bokstein
SCShlomi Constantini
Shlomi Constantini
SBShay Ben‐Shachar
Shay Ben‐Shachar
Background: Neurofibromatosis type 1 (NF1) is the most common autosomal dominant neurocutaneous disease with a prevalence of 1:2500. Approximately, 50% of the cases are sporadic. Advanced paternal age is associated with germline mutations and autosomal diseases. We aimed to use NF1 as a paradigm to study the effect of parental age on sporadic mutation rates for both advanced and younger parental ages.Methods: The medical charts of 118 NF1 pediatric patients followed in a specialized Israeli NF1 clinic were evaluated. Thirty‐one cases were diagnosed by genetic tests and 87 by NIH clinical criteria. Sixty‐four cases (54%) had a negative family history of NF1 (sporadic cases). Data on parental ages at the time of the children's birth were compared to the national population database.Results: Parental age of children with sporadic NF1 was higher than the general population (32.7 years vs. 30.1 years, respectively, for the mothers and 36.5 years vs. 32.6 years, respectively, for the fathers; P < 0.0001 for both groups). In contrast, the age of the mothers and the fathers in the familial cases (30.3 and 33.9 years, respectively) did not differ from the general population. Significantly, fewer fathers of the sporadic group had been 25–29 years old at their child's birth compared with fathers in the general population (7.8% vs. 21%, respectively, P = 0.009), and significantly more fathers were ≥40 years old (29.7% vs. 13.6%, respectively, P = 0.0002). Differences in maternal age between these two groups were less prominent.Conclusion: Parents of sporadic NF1 cases are older. The risk for sporadic NF1 was lower when the fathers were younger at the time of the affected child's birth, and gradually increased with paternal age.

10 August 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MMM. Mauda-Havakuk
M. Mauda-Havakuk
BSB. Shofty
B. Shofty
SBS. Ben-Shachar
S. Ben-Shachar
LBL. Ben-Sira
L. Ben-Sira
SCS. Constantini
S. Constantini
FBF. Bokstein
F. Bokstein
BACKGROUND AND PURPOSE: Neurofibromatosis type 1 is a common tumor predisposition syndrome. The aim of this study was to characterize the radiologic presentation of patients with neurofibromatosis type 1 with widespread spinal disease and to correlate it to clinical presentation and outcome. MATERIALS AND METHODS: We conducted a historical cohort study of adult patients with neurofibromatosis type 1 with spinal involvement. Longitudinal clinical evaluation included pain and neurologic deficits. Radiologically, spinal involvement was classified according to a novel classification system, and a radiologic risk score was calculated. RESULTS: Two hundred fifty-seven adult patients with neurofibromatosis type 1 are followed in our center. Thirty-four of these patients qualified for inclusion in this study. Three independent factors were found to be associated with increased risk for neurologic deficit: 1) bilateral tumors at the same level in the cervical region that approximated each other, 2) paraspinal tumors at the lumbar region, and 3) intradural lesions. On the basis of these factors, we calculated a combined risk score for neurologic deficits for each patient. We found a clear correlation between patient status and the calculated radiologic risk score. Patients with neurologic deficits were found to have a higher risk score (9 ± 8.3) than patients without neurologic deficits (2.5 ± 2.9, P < .05). Patients who progressed during the follow-up period had significantly higher scores at presentation than patients with stable conditions (9.9 ± 8.73 versus 3.9 ± 5.3, respectively; P < .05). CONCLUSIONS: In this series, neurologic deficit is correlated with tumor burden and subtype. We found no direct correlation with tumor burden and pain. Our novel radiologic classification scoring system may be used to predict increased risk for neurologic morbidity.